Induction of Autologous Graft vs Host Disease: An Immunotherapeutic Approach to Eliminate Residual Leukemia After Autologous Bone Marrow Transplantation

  • S. J. Noga
  • A. D. Hess


Graft vs host disease (GVHD) remains a major complication following allogeneic bone marrow transplantation (BMT) [1]. The large number of peripheral blood T lymphocytes which contaminate the graft during bone marrow (BM) harvesting are thought to mediate GVHD by responding to foreign major and/or minor histocompatibility antigen differences of the recipient [2].


Graft Versus Host Disease Allogeneic Bone Marrow Transplantation Autologous Bone Marrow Transplantation Bone Marrow Transplantation Recipient Autologous Graft 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Santos GW (1984) Bone marrow transplantation in leukemia: current status. Cancer 54: 2732–2740PubMedCrossRefGoogle Scholar
  2. 2.
    Santos GW, Hess AD, Vogelsang GB (1985) Graft-versus-host reactions and disease. Immunol Rev 88: 169–192PubMedCrossRefGoogle Scholar
  3. 3.
    Santos GW (1988) Problems and strategies for bone marrow transplantaton in acute leukemia and chornic myelogenous leukemia. Cancer Detect Prev 12: 589–596PubMedGoogle Scholar
  4. 4.
    Martin PJ, Hansen J A, Storb R, Thomas ED (1987) Human marrow transplantation: an immunological perspective. Adv Immunol 40: 379–438PubMedCrossRefGoogle Scholar
  5. 5.
    Noga SJ, Wagner JE, Rowley SD, Davis JM, Vogelsang GB, Hess AD, Saral R, Santos GW, Donnenberg AD (1990) Using elutriation to engineer bone marrow allografts. Prog Clin Biol Res 333: 345–368PubMedGoogle Scholar
  6. 6.
    Yeager AM, Rowley SD, Kaizer H, Colvin OM, Braine HG, Saral R, Santos GW (1989) Autologous bone marrow transplantation in acute nonlymphocytic leukemia: studies of ex vivo chemo-purging with 4-hydroperoxycyclophosphamide. In: Gale RP, Champlin RE (eds) Bone marrow transplantation: current controversies. Liss, New York, pp 157– 166Google Scholar
  7. 7.
    Gluckman E, Devergie A, Sohier J, Sauret JH (1980) Graft-versus-host disease in recipients of syngeneic bone marrow. Lancet 1: 253PubMedGoogle Scholar
  8. 8.
    Thien SW, Goldman JM, Galton DG (1981) Acute “graft-versus-host disease” after auto- grafting for chronic granulocytic leukemia in transplantation. Ann Intern Med 94:210– 216Google Scholar
  9. 9.
    Hood AF, Vogelsang GV, Black LP, Farmer ER, Santos GW (1987) Acute graft-versus- host disease. Development following autologous and syngeneic bone marrow transplan¬tation. Arch Dermatol 123: 745–750Google Scholar
  10. 10.
    Billingham RE (1967) The biology of graft-versus-host reaction. Harvey Lect 62: 21–28Google Scholar
  11. 11.
    Glazier A, Tutschka PJ, Farmer ER, Santos GW (1983) Graft-versus-host disease in cyclosporin A treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med 158: 1–8PubMedCrossRefGoogle Scholar
  12. 12.
    Sorokin R, Kimura H, Schroder K, Wilson DH, Wison DB (1986) Cyclosporin-induced autoimmunity. Conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats. J Exp Med 164:1615– 1625PubMedCrossRefGoogle Scholar
  13. 13.
    Glazier A, Tutschka PJ, Farmer ER (1983) Studies on the immunobiology of syngeneic and autologous graft-versus-host disease in cyclosporin treated rats. Transplant Proc 15: 3035–3041Google Scholar
  14. 14.
    Tutschka PJ, Hess AD, Beschorner WE, Farmer ER, Saral R, Brookmeyer R, Santos GW (1983) Cyclosporine in clinical marrow transplantation: the Baltimore experience. Transplant Proc 15: 2613–2616Google Scholar
  15. 15.
    Hess AD, Fischer AC (1989) Immune mechanisms in cyclosporine-induced syngeneic graft-versus-host disease. Transplantation 48: 895–900PubMedCrossRefGoogle Scholar
  16. 16.
    Hess AD, Horwitz L, Beschorner WE, Santos GW (1985) Development of graft-versushost disease-like syndrome in cyclosporine treated rats after syngeneic bone marrow transplantation 1. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specific including autoreactivity. J Exp Med 161 :718-730CrossRefGoogle Scholar
  17. 17.
    Hess AD, Fischer AC, Beschorner WE (1990) Effector mechanisms in cyclosporine A induced syngeneic graft-versus-host disease: role of CD4+ and CD8+ T lymphocyte subsets. J Immunol 140: 526–533Google Scholar
  18. 18.
    Beschorner WE, Shinn CA, Fischer AC, Santos GW, Hess AG (1988) Cyclosporine- induced pseudo graft-versus-host disease in the early post cyclosporine period. Transplantation 46 [Suppl 1]: 112–117Google Scholar
  19. 19.
    Shinozawa T, Beschorner WE, Hess AD (1990) Prolonged administration of cyclospo¬rine (CsA) and the thymus. Irreversible immunopathologic changes associated with autologous pseudo-graft-versus-host disease (GVHD). Transplantation 50 (1): 106–111PubMedCrossRefGoogle Scholar
  20. 20.
    Cheney RT, Sprent J (1985) Capacity of cyclosporine to induce autograft-versus-host disease and impair intrathymic T cell differentiation. Transplant Proc 17: 528–530Google Scholar
  21. 21.
    Jenkins MK, Schwartz RN, Pardoll DM (1988) Effects of cyclosporin A on T cell development and clonal deletion. Science 241: 1655–1658PubMedCrossRefGoogle Scholar
  22. 22.
    Hess AD, Jones RJ, Vogelsang GB, Santos GW (1990) Syngeneic graft-versus-host disease: fundamental mechanisms and clinical applications. In: Gale RP, Champlin R (eds) New strategies in bone marrow transplantation, UCLA symposia on molecular and cellular biology. Whiley-Liss, New York, NY, pp 61–72Google Scholar
  23. 23.
    Jones RJ, Vogelsang GB, Hess AD, Farmer ER, Mann RB, Geller RB, Piantadosi S, Santos GW (1989) Induction of graft-versus-host disease following autologous bone marrow transplantation. Lancet 1: 754–757PubMedCrossRefGoogle Scholar
  24. 24.
    Geller RB, Esa AH, Beschorner WE, Frondoza CG, Santos GW, Hess AD (1989) Successful in vitro graft-versus-tumor effect against an la-bearing tumor using cyclosporine-induced syngeneic graft-versus-host disease in the rat. Blood 74:1165– 1172PubMedGoogle Scholar
  25. 25.
    Noga S, Horwitz L, Hess A (1990) Gamma interferon (INF) augments the graft-vs- tumor effect of syngeneic graft -vs-host-disease (SGVHD) in the rat. Twelfth International RES Congress, 14–18 Oct 1990, Crete, CreeceGoogle Scholar
  26. 26.
    Ostraud-Rosenberg S, Thakur A, Clements V (1990) Rejection of mouse sarcoma cells after transplantation of MHC class II genes. J Immunol 144: 4068–4071Google Scholar
  27. 27.
    Freund YR, Dedrick RL, Jones PP (1990) cis-Acting sequences required class II gene regulation by interferon-y and tumor necrosis factor-a in a murine macrophage cell line. J Exp Med 171: 1283–1299PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • S. J. Noga
    • 1
  • A. D. Hess
    • 1
  1. 1.The Johns Hopkins Oncology CenterBaltimoreUSA

Personalised recommendations